Articles On Creso Pharma (ASX:CPH)

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

The 420 Day is unofficially the World Marijuana Day, and we look at the possible origins of this day Cannabis stocks have been falling, but there’s still a lot of promise We take a look at the cannabis stocks on the ASX over the past week...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

The growth generated by Mernova validates Creso Pharma’s strategy to drive revenue growth with a simultaneous focus on cost management. Creso Pharma (ASX:CPH) announced that its 100%-owned Canadian cannabis cultivation and sales division, M...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The number of Aussies using legal instead of illicit medical cannabis is rising The main reason for using prescribed medicinal cannabis was chronic pain, says Sydney Uni survey We take a look at what made the news in ASX weed stocks this p...

Chemist Warehouse joins WNX JV to develop new cannabis products Neurotech launches new clinical program for its NTI164 drug in Rett Syndrome InhaleRx nabs approval for Phase 1 IRX211 clinical trial for Complex Regional Pain Syndrome   Wel...

Stock exchange officials have formally censured Nedlands-based medical cannabis hopeful Creso Pharma over an unapproved share issue involving founder and former chairman Adam Blumenthal.

ASX cannabis stocks provide a valuable service to the many thousands of Australians who benefit from the legal, medicinal benefits of their product. All told, the cannabis shares have grown, cured, and prepared medicinal marijuana products...

Several ASX lithium and resources companies are due to release shares from escrow in March Pilbara Minerals will release 86,528 shares issued to non-executive directors under its NED fee sacrifice offer Newly listed Bubalus Resources will...

Twitter to allow cannabis companies to advertise in US states where it’s legal Elixnol comes out on top with CannaCare Health arbitration awarded in their favour Avecho expands CBD soft-gel capsule trials with the Lambert Initiative   Twi...

Medicinal Cannabis specialist Creso Pharma (CPH) has tapped investors for $2 million through a share placement The fresh funds will be used for sales and marketing in the US, a phase II psilocybin clinical trial and potential M&A opp...

ASX slides to a 1.0% dip as Hump Day fails to live up to its name. Unemployment has to rise to ease inflation, according to very-employed RBA chief. Omnia Metals (ASX:OM1) leads the winners worth watching among Small Caps today.   The ASX...

Australia has become the first country in the world to officially recognise psychedelics as medicines, which is good news for Creso Pharma. Creso Pharma (ASX:CPH) has announced its wholly owned subsidiary, Halucenex Life Sciences Inc will p...

Creso looks to potentially spin out psychedelic subsidiary  Two studies show Memphasys’ Felix reproductive tech outperforms WOA’s Dirty Clean Food brand nabs WHSmith retail deal   Yesterday the big news in the health sector was the Thera...

The TGA has changed its classification of psilocybin and MDMA As a result, Australia has become the first country in the world to recognise psychedelics as medicine ASX psychedelic related stocks surged on Monday   Australia has become th...

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Creso Pharma has recorded a total FY22 unaudited revenue and several key milestones on its path to becoming profitable “as soon as practically possible”.   Aussie pot stock Creso Pharma (ASX:CPH) has released its FY22 results including unau...

US States who allow recreational cannabis see less codeine demand WA GP wants Snoop Dogg to drop into parliament to chat cannabis reform Neurotech nabs pre-submission meeting with US FDA for CBD drug NTI164   A Cornell University study ha...

The ASX 200 dropped 0.30% and the ASX XEC declined 0.20% Only 4 out of 11 sectors were higher, with Utilities leading the way Waste management company M8 Sustainable receives unsolicited takeover offer   The ASX 200 declined 0.30% today,...

Creso Pharma’s (CPH) wholly-owned subsidiary Mernova Medicinal bolsters its Canadian footprint, expanding into its sixth province The expansion is caused by the growing demand for Mernova’s high-quality recreational cannabis products...

Creso Pharma’s wholly-owned Canadian subsidiary Mernova Medicinal Inc has increased its footprint  in Canada following expansion into Manitoba. Aussie pot stock Creso Pharma (ASX:CPH) said it is the sixth Canadian province that Mernova has...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Germany: Next target for cannabis producers, huge market and could be live in 12 months Other Euro states about to legislate on industry in next few years Stockhead reached out to Little Green Pharma’s founder and CEO, Fleta Solomon   Fol...

Creso Pharma’s (CPH) subsidiary Mernova Medicinal has won seven new product listings in Nova Scotia The Canadian subsidiary’s products were accepted by the Nova Scotia Liquor Corporation, effectively doubling its total listings in the pr...

Penington Institute says pot-related law enforcement costs us $1.7 billion a year   Local cannabis is missing out on international and domestic market opportunities Aussie medicinal cannabis revenue was around $230 million in 2021   Decri...

Creso Pharma’s (CPH) Canadian-based subsidiary, Halucenex Life Sciences, administers the first dose of its synthetic psilocybin product in a phase two clinical trial The first of 20 participants received both doses of the Lucenex-branded dr...

US President Joe Biden has turned the Medical Marijuana Research Bill into law, changing how scientists in the country can do research on marijuana. Aussie pot stock Creso Pharma (ASX:CPH) has welcomed news of the passing of the Medical Mar...

Global share markets rally continue to rally in November despite ongoing economic and geopolitical pressures Avenira led the gainers in November after reporting a positive update on its proposed DSO Phosphate Project Gut health company Mic...

James Ellingford garnered unwelcome attention for medicinal cannabis play Creso Pharma by publicly documenting on TikTok his turbulent relationship with a woman 35 years younger than him.

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

ASX 200 ends 0.7% higher. Small cap index rises 0.2% Codrus latest REE newcomer to go tik-tik boom! All of the top 15 small cap gainers today are in the resources space. The benchmark has risen 0.7% and the ASX Emerging Companies (XEC) in...

ASX 200 ends 0.7% higher Small cap index flat NYM, BEZ, CPH best in show    Lithium keeps finding another gear. The analysts at Citi lifted target forecasts after the Marrickville government and others besides prepare to throw some suppor...

Well… that was Tuesday, kiddos. A reasonable day for the ASX, all things considered, and a hearty well done to Besra Gold (ASX:BEZ), Redcastle (ASX:RC1) and Creso Pharma (ASX:CPH) for gaining quite a bit of relative value today, adding 47.5...

The Creso Pharma Ltd (ASX: CPH) share price is soaring 40% today. However, earlier, the company’s share price exploded 70%. ASX cannabis shares Incannex Healthcare Ltd (ASX: IHL) and Bod Australia Ltd (ASX: BOD) are also up 6% and 14% re...

Bod Australia returns positive results from Phase 1 trial Paradigm and Impedimed make executive changes Creso Pharma no longer the subject of ASIC investigation Cannabis stock Bod Australia (ASX:BOD) announced positive results from its Ph...

Cannabis player Creso Pharma has taken the final step in its acquisition of Health House International (ASX:HHI) by signing to Scheme Implementation Deed for a total value of up to around $4.6 million – based on a Creso share price of A$0.0...

The Core Lithium Ltd (ASX: CXO) share price is back on form at last. In morning trade, the lithium miner’s shares are up over 4% to $1.46. This will be a welcome relief to shareholders which have watched Core Lithium’s shares record decl...

Medicinal cannabis play Creso Pharma has announced that Boaz Wachtel will step into the role of non-executive chairman, replacing Dr James Ellingford, who has been caught up in a bizarre TikTok spectacle.

Core Lithium Ltd (ASX: CXO) shares have been in the news a lot lately. This ASX 200 lithium stock is one of the wildest shares on the ASX 200. Just this week, Core Lithium rose almost 12% on Monday, only to drop 16% on Tuesday, 5.4% on We...

The IGO Ltd (ASX: IGO) share price closed 0.69% lower today at $15.86. That’s exactly when the IGO annual general meeting took place in Perth, commencing at 3pm AEDT. Chair Michael Nossal told investors at the meeting that the nickel and...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to stay in positive territory. At the time of writing, the benchmark index is up 0.1% to 7,129 points. Four ASX shares that are climbing more than most today are lis...

The Perpetual Limited (ASX: PPT) share price is tumbling on news of its planned takeover of fund management business Pendal Group Ltd (ASX: PDL). Early this morning, the companies announced a change to the consideration mix on the table fo...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up 0.1% to 7,132.1 points. Four ASX shares that have failed to follow the market higher today ar...

Nov 17 (Reuters) - Creso Pharma: * REPLACEMENT OF CHAIRMAN * BOAZ WACHTEL WILL REPLACE JAMES ELLINGFORD AS NON-EXECUTIVE CHAIRMAN EFFECTIVE IMMEDIATELY Source text for Eikon: Further company coverage:

The ASX Ltd (ASX: ASX) share price is in the red in early trade, down 2.5%. This comes after Australia’s largest securities exchange said it is reassessing all aspects of its CHESS replacement project. ASX said it had conducted its own i...

Island Pharma gets patent in Canada Nova Eye beats sales guidance Health House sells stake in cannabis company CanPharma Canada approved Island Pharma patent Antiviral drug development company, Island Pharma (ASX:ILA), announced that a ke...

Two more US states join the 19 that already allow legal recreational cannabis use ECS Botanics’ Victorian medical cannabis facility is safe from flooding in the state, so far Cann looks to commercialise its Satipharm CBD capsules for over-...

ASX cannabis shares haven’t exactly been smoking hot this year. That’s partly because similar headwinds facing cannabis stocks worldwide have hit the sector. Firstly, there’s rocketing interest rates. Higher rates have hit growth sha...